The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Epstein–Barr virus infection and nasopharyngeal carcinoma
Open accessAbstract
Epstein–Barr virus (EBV) is associated with multiple types of human cancer, including lymphoid and epithelial cancers. The closest association with EBV infection is seen in undifferentiated nasopharyngeal carcinoma (NPC), which is endemic in the southern Chinese population. A strong association between NPC risk and the HLA locus at chromosome 6p has been identified, indicating a link between the presentation of EBV antigens to host immune cells and NPC risk. EBV infection in NPC is clonal in origin, strongly suggesting that NPC develops from the clonal expansion of a single EBV-infected cell. In epithelial cells, the default program of EBV infection is lytic replication. However, latent infection is the predominant mode of EBV infection in NPC. The establishment of latent EBV infection in pre-invasive nasopharyngeal epithelium is believed to be an early stage of NPC pathogenesis. Recent genomic study of NPC has identified multiple somatic mutations in the upstream negative regulators of NF-κB signalling. Dysregulated NF-κB signalling may contribute to the establishment of latent EBV infection in NPC. Stable EBV infection and the expression of latent EBV genes are postulated to drive the transformation of pre-invasive nasopharyngeal epithelial cells to cancer cells through multiple pathways. This article is part of the themed issue ‘Human oncogenic viruses’.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Wang, K., Yuen, S. T., Xu, J., Lee, S. P., Yan, H. H. N., Shi, S. T., Siu, H. C., Deng, S., Chu, K. M., Law, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2983 · Cited by 1,045
Epidemiology of nasopharyngeal carcinoma
Yu, M. C., & Yuan, J.-M. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x02000858 · Cited by 936
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
Raab-Traub, N., & Flynn, K. (1986) · Cell · doi:10.1016/0092-8674(86)90803-2 · Cited by 912
Epstein–Barr virus: more than 50 years old and still providing surprises
Young, L. S., Yap, L. F., & Murray, P. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.92 · Cited by 856
Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H., & Rickinson, A. B. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02568.x · Cited by 711
Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., & Raab-Traub, N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331103 · Cited by 620
Focus on nasopharyngeal carcinoma
Lo, K. W., To, K. F., & Huang, D. P. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00119-9 · Cited by 559
Self-citationCyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
Nachmani, D., Stern-Ginossar, N., Sarid, R., & Mandelboim, O. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.03.003 · Cited by 470
An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survival
Choy, E. Y.-W., Siu, K.-L., Kok, K.-H., Lung, R. W.-M., Tsang, C. M., To, K.-F., Kwong, D. L.-W., Tsao, S. W., & Jin, D.-Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072581 · Cited by 462
Self-citationCutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
Haneklaus, M., Gerlic, M., Kurowska-Stolarska, M., Rainey, A.-A., Pich, D., McInnes, I. B., Hammerschmidt, W., O’Neill, L. A. J., & Masters, S. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200312 · Cited by 411
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci
Bei, J.-X., Li, Y., Jia, W.-H., Feng, B.-J., Zhou, G., Chen, L.-Z., Feng, Q.-S., Low, H.-Q., Zhang, H., He, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.601 · Cited by 410
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus
Cheung, S. T., Huang, D. P., Hui, A. B. Y., Lo, K. W., Ko, C. W., Tsang, Y. S., Wong, N., Whitney, B. M., & Lee, J. C. K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<121::aid-ijc21>3.0.co;2-f · Cited by 395
Self-citationThe genomic landscape of nasopharyngeal carcinoma
Lin, D.-C., Meng, X., Hazawa, M., Nagata, Y., Varela, A. M., Xu, L., Sato, Y., Liu, L.-Z., Ding, L.-W., Sharma, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3006 · Cited by 366
Epstein–Barr virus latent genes
Kang, M.-S., & Kieff, E. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.84 · Cited by 361
Dawson, C. W., Port, R. J., & Young, L. S. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.004 · Cited by 355
Hino, R., Uozaki, H., Murakami, N., Ushiku, T., Shinozaki, A., Ishikawa, S., Morikawa, T., Nakaya, T., Sakatani, T., Takada, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3070 · Cited by 344
The role of Epstein–Barr virus in epithelial malignancies
Tsao, S., Tsang, C. M., To, K., & Lo, K. (2015) · The Journal of Pathology · doi:10.1002/path.4448 · Cited by 337
Self-citationLoss of the Tumor Suppressor PML in Human Cancers of Multiple Histologic Origins
Gurrieri, C., Capodieci, P., Bernardi, R., Scaglioni, P. P., Nafa, K., Rush, L. J., Verbel, D. A., Cordon-Cardo, C., & Pandolfi, P. P. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh043 · Cited by 334
Tsai, C.-N., Tsai, C.-L., Tse, K.-P., Chang, H.-Y., & Chang, Y.-S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152059399 · Cited by 315
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
Li, Y. Y., Chung, G. T. Y., Lui, V. W. Y., To, K.-F., Ma, B. B. Y., Chow, C., Woo, J. K., Yip, K. Y., Seo, J., Hui, E. P., et al. (2017) · Nature Communications · doi:10.1038/ncomms14121 · Cited by 309
Self-citationEtiological factors of nasopharyngeal carcinoma
Tsao, S. W., Yip, Y. L., Tsang, C. M., Pang, P. S., Lau, V. M. Y., Zhang, G., & Lo, K. W. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.02.006 · Cited by 300
Self-citationHigh frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
Lo, K. W., Kwong, J., Hui, A. B., Chan, S. Y., To, K. F., Chan, A. S. Y., Chow, L. S. N., Teo, P., Johnson, P. J., & Huang, D. P. (2001) · PubMed · Cited by 290
Self-citationEpstein–Barr virus RNA confers resistance to interferon‐α‐induced apoptosis in Burkitt's lymphoma
Nanbo, A., Inoue, K., Adachi‐Takasawa, K., & Takada, K. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.954 · Cited by 276
Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong, J., Lo, K. W., To, K., Teo, P. M. L., Johnson, P. J., & Huang, D. P. (2002) · PubMed · Cited by 259
Self-citationEpstein-Barr virus and nasopharyngeal carcinoma
Young, L. S., & Dawson, C. W. (2014) · Chinese Journal of Cancer · doi:10.5732/cjc.014.10197 · Cited by 253
Gruhne, B., Sompallae, R., Marescotti, D., Kamranvar, S. A., Gastaldello, S., & Masucci, M. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810619106 · Cited by 252
Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling
Tsai, C.-L., Li, H.-P., Lu, Y.-J., Hsueh, C., Liang, Y., Chen, C.-L., Tsao, S. W., Tse, K.-P., Yu, J.-S., & Chang, Y.-S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2194 · Cited by 245
Self-citationSengupta, S., den Boon, J. A., Chen, I.-H., Newton, M. A., Dahl, D. B., Chen, M., Cheng, Y.-J., Westra, W. H., Chen, C.-J., Hildesheim, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4399 · Cited by 239
Lo, K.-W., Chung, G. T.-Y., & To, K.-F. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.011 · Cited by 220
Self-citationNF-κB Inhibits Gammaherpesvirus Lytic Replication
Brown, H. J., Song, M. J., Deng, H., Wu, T.-T., Cheng, G., & Sun, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8532-8540.2003 · Cited by 219
Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
Wang, H.-B., Zhang, H., Zhang, J.-P., Li, Y., Zhao, B., Feng, G.-K., Du, Y., Xiong, D., Zhong, Q., Liu, W.-L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7240 · Cited by 215
Self-citationEffect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells
Mrizak, D., Martin, N., Barjon, C., Jimenez-Pailhes, A.-S., Mustapha, R., Niki, T., Guigay, J., Pancré, V., de Launoit, Y., Busson, P., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju363 · Cited by 211
Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells
Shannon-Lowe, C. D., Neuhierl, B., Baldwin, G., Rickinson, A. B., & Delecluse, H.-J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510512103 · Cited by 206
The significance of LMP1 expression in nasopharyngeal carcinoma
Tsao, S. W., Tramoutanis, G., Dawson, C. W., Lo, A. K. F., & Huang, D. P. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x02000901 · Cited by 204
Self-citationEpstein–Barr Virus Infection as an Epigenetic Driver of Tumorigenesis
Kaneda, A., Matsusaka, K., Aburatani, H., & Fukayama, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3919 · Cited by 204
Baumforth, K. R. N., Birgersdotter, A., Reynolds, G. M., Wei, W., Kapatai, G., Flavell, J. R., Kalk, E., Piper, K., Lee, S., Machado, L., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070845 · Cited by 200
Kong, Q.-L., Hu, L.-J., Cao, J.-Y., Huang, Y.-J., Xu, L.-H., Liang, Y., Xiong, D., Guan, S., Guo, B.-H., Mai, H.-Q., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000940 · Cited by 199
The Epstein–Barr Virus BART microRNAs target the pro-apoptotic protein Bim
Marquitz, A. R., Mathur, A., Nam, C. S., & Raab-Traub, N. (2011) · Virology · doi:10.1016/j.virol.2011.01.028 · Cited by 194
Tse, K.-P., Su, W.-H., Chang, K.-P., Tsang, N.-M., Yu, C.-J., Tang, P., See, L.-C., Hsueh, C., Yang, M.-L., Hao, S.-P., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.07.007 · Cited by 191
Hypermethylation of the p16 gene in nasopharyngeal carcinoma.
Lo, K. W., Cheung, S., Leung, S. F., van Hasselt, A., Tsang, Y. S., Mak, K. F., Chung, Y. F., Woo, J. K. S., Lee, J. C., & Huang, D. P. (1996) · PubMed · Cited by 188
Self-citationImmune Evasion by Epstein-Barr Virus
Ressing, M. E., van Gent, M., Gram, A. M., Hooykaas, M. J. G., Piersma, S. J., & Wiertz, E. J. H. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_12 · Cited by 182
Zheng, H., Dai, W., Cheung, A. K. L., Ko, J. M. Y., Kan, R., Wong, B. W. Y., Leong, M. M. L., Deng, M., Kwok, T. C. T., Chan, J. Y.-W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607606113 · Cited by 182
Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg, N. J., Rajadurai, P., & Raab‐Traub, N. (2003) · PubMed · Cited by 179
Inhibition of IFN-γ Signaling by an Epstein-Barr Virus Immediate-Early Protein
Morrison, T. E., Mauser, A., Wong, A., Ting, J. P.-Y., & Kenney, S. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00226-6 · Cited by 167
Chen, H., Hutt-Fletcher, L., Cao, L., & Hayward, S. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4139-4148.2003 · Cited by 166
High resolution allelotype of microdissected primary nasopharyngeal carcinoma.
Lo, K. W., Teo, P., Hui, A. B., To, K. F., Tsang, Y. S., Chan, S. Y., Mak, K. F., Lee, J. C. K., & Huang, D. P. (2000) · PubMed · Cited by 163
Self-citationSivachandran, N., Sarkari, F., & Frappier, L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000170 · Cited by 162
The Epstein-Barr Virus BARF1 Gene Encodes a Novel, Soluble Colony-Stimulating Factor-1 Receptor
Strockbine, L. D., Cohen, J. I., Farrah, T., Lyman, S. D., Wagener, F., DuBose, R. F., Armitage, R. J., & Spriggs, M. K. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4015-4021.1998 · Cited by 160
Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells
Tsang, C. M., Yip, Y. L., Lo, K. W., Deng, W., To, K. F., Hau, P. M., Lau, V. M. Y., Takada, K., Lui, V. W. Y., Lung, M. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202637109 · Cited by 159
Self-citationThe Latent Membrane Protein 1 (LMP1)
Kieser, A., & Sterz, K. R. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_4 · Cited by 153
Regulatory T Cells Secreting IL-10 Dominate the Immune Response to EBV Latent Membrane Protein 1
Marshall, N. A., Vickers, M. A., & Barker, R. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6183 · Cited by 152
EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival
Kang, D., Skalsky, R. L., & Cullen, B. R. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004979 · Cited by 150
Latent Membrane Protein 2 (LMP2)
Çen, O., & Longnecker, R. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_5 · Cited by 150
p16 gene alterations in nasopharyngeal carcinoma.
Lo, K. W., Huang, D. P., & Lau, K. (1995) · PubMed · Cited by 149
Self-citationEpstein–Barr Virus and Nasopharyngeal Carcinoma
Zhou, X., Xiao, X., Chen, F., Huang, T., & Zhang, Z. (2014) · Wiley eBooks · doi:10.1002/9781118826621.ch14 · Cited by 142
Constitutive activation of distinct NF‐κB signals in EBV ‐associated nasopharyngeal carcinoma
Chung, G. T., Lou, W. P.-K., Chow, C., To, K., Choy, K. W., Leung, A. W.-C., Tong, C. Y., Yuen, J. W.-F., Ko, C., Yip, T. T., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4239 · Cited by 140
Self-citationCohen, J. I., & Lekstrom, K. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7627-7632.1999 · Cited by 135
Li, L., Li, C., Mao, H., Du, Z., Chan, W., Murray, P. G., Luo, B., Chan, A. T. �., Mok, T. S. K., Chan, F. K. L., et al. (2016) · Scientific Reports · doi:10.1038/srep26591 · Cited by 130
Hajek, M., Sewell, A. B., Kaech, S. M., Burtness, B. A., Yarbrough, W. G., & Issaeva, N. (2017) · Cancer · doi:10.1002/cncr.30570 · Cited by 123
New insights into the role of PML in tumour suppression
Salomoni, P., Ferguson, B. J., Wyllie, A. H., & Rich, T. (2008) · Cell Research · doi:10.1038/cr.2008.58 · Cited by 119
Histology of the human nasopharyngeal mucosa.
Ali, M. (1965) · PubMed · Cited by 117
Martel-Renoir, D., Grunewald, V., Touitou, R., Schwaab, G., & Joab, I. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-6-1401 · Cited by 117
Epstein–Barr Virus: Diseases Linked to Infection and Transformation
Jha, H. C., Pei, Y., & Robertson, E. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01602 · Cited by 116
The role of miRNAs and EBV BARTs in NPC
Marquitz, A. R., & Raab‐Traub, N. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.001 · Cited by 115
Host–tumor interactions in nasopharyngeal carcinomas
Gourzonès, C., Barjon, C., & Busson, P. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.002 · Cited by 115
Hui, A. B., Or, Y. Y., Takano, H., Tsang, R. K., To, K., Guan, X., Sham, J. S., Hung, K., Lam, C. N. Y., van Hasselt, C. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0648 · Cited by 115
Self-citationBirdwell, C. E., Queen, K. J., Kilgore, P. C. S. R., Rollyson, P. A., Trutschl, M., Cvek, U., & Scott, R. S. (2014) · Journal of Virology · doi:10.1128/jvi.00972-14 · Cited by 114
Tang, M., Lautenberger, J. A., Gao, X., Sezgın, E., Hendrickson, S. L., Troyer, J. L., David, V. A., Guan, L., MCINTOSH, C. E., Guo, X., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003103 · Cited by 111
Fang, C., Lee, C., Wu, C., Chang, Y., Yu, S., Chou, S., Huang, P., Chen, C., Hou, J., Chang, Y., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24179 · Cited by 108
Kondo, S., Wakisaka, N., Muramatsu, M., Zen, Y., Endo, K., Murono, S., Sugimoto, H., Yamaoka, S., Pagano, J. S., & Yoshizaki, T. (2011) · Journal of Virology · doi:10.1128/jvi.00188-11 · Cited by 107
Epstein–Barr virus particles induce centrosome amplification and chromosomal instability
Shumilov, A., Tsai, M., Schlosser, Y. T., Kratz, A.-S., Bernhardt, K., Fink, S., Mizani, T., Lin, X., Jauch, A. S., Mautner, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14257 · Cited by 105
Xiong, D., Du, Y., Wang, H., Zhao, B., Zhang, H., Li, Y., Hu, L.-J., Cao, J.-Y., Zhong, Q., Liu, W.-L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513359112 · Cited by 103
Self-citationEpstein–Barr Virus DNase (BGLF5) induces genomic instability in human epithelial cells
Wu, C.-C., Liu, M., Chang, Y., Fang, C., Chou, S., Liao, H.-W., Kuo, K.-L., Hsu, S.-L., Chen, Y.-R., Wang, P., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1169 · Cited by 103
Contributions of the Epstein-Barr Virus EBNA1 Protein to Gastric Carcinoma
Sivachandran, N., Dawson, W. O., Young, L. S., Liu, F., Middeldorp, J. M., & Frappier, L. (2011) · Journal of Virology · doi:10.1128/jvi.05623-11 · Cited by 103
Epstein-Barr Virus Nuclear Antigen 1 Hijacks the Host Kinase CK2 To Disrupt PML Nuclear Bodies
Sivachandran, N., Cao, J. Y., & Frappier, L. (2010) · Journal of Virology · doi:10.1128/jvi.01183-10 · Cited by 103
Epstein-Barr Virus Lytic Cycle Reactivation
McKenzie, J., & El-Guindy, A. S. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_8 · Cited by 103
Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma
Li, Y., Liu, Z., Lin, Z.-R., Xu, L.-H., Zhong, Q., & Zeng, M. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.961874 · Cited by 100
Chan, A. S., To, K., Lo, K. W., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10689 · Cited by 98
Self-citationKamranvar, S. A., & Masucci, M. G. (2011) · Leukemia · doi:10.1038/leu.2011.35 · Cited by 97
Bentz, G. L., Liu, R., Hahn, A. M., Shackelford, J., & Pagano, J. S. (2010) · Virology · doi:10.1016/j.virol.2010.03.014 · Cited by 96
EBV Lytic-Phase Protein BGLF5 Contributes to TLR9 Downregulation during Productive Infection
van Gent, M., Griffin, B. D., Berkhoff, E. G. M., van Leeuwen, D., Boer, I. G. J., Buisson, M., Hartgers, F. C., Burmeister, W. P., Wiertz, E. J. H. J., & Ressing, M. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903120 · Cited by 94
Zhang, G., Tsang, C. M., Deng, W., Yip, Y. L., Lui, V. W. Y., Wong, S. C. C., Cheung, A. L. M., Hau, P. M., Zeng, M., Lung, M. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062284 · Cited by 93
Self-citationDai, W., Cheung, A. K. L., Ko, J. M. Y., Cheng, Y., Zheng, H., Ngan, R. K., Ng, W. T., Lee, A. W. M., Yau, C. C., Lee, V. H.-F., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.451 · Cited by 93
Kung, C.-P., & Raab‐Traub, N. (2008) · Journal of Virology · doi:10.1128/jvi.00125-08 · Cited by 93
Tsang, C. M., Zhang, G., Seto, E., Takada, K., Deng, W., Yip, Y. L., Man, C., Hau, P. M., Chen, H., Cao, Y., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25173 · Cited by 92
Self-citationThe Epstein-Barr Virus Encoded BART miRNAs Potentiate Tumor Growth In Vivo
Qiu, J. J., Smith, P., Leahy, L., & Thorley‐Lawson, D. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004561 · Cited by 89
Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis
Takada, K. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.007 · Cited by 88
Nanbo, A., Yoshiyama, H., & Takada, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12280-12285.2005 · Cited by 86
Frappier, L. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_1 · Cited by 85
CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma
Lun, S. W., Cheung, S., Cheung, P. F. Y., To, K., Woo, J. K. S., Choy, K. W., Chow, C., Cheung, C. C., Chung, G. T., Cheng, A. S.-H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052426 · Cited by 82
Self-citationYang, C.-F., Yang, G.-D., Huang, T.-J., Li, R., Chu, Q.-Q., Xu, L., Wang, M.-S., Cai, M.-D., Zhong, L., Wei, H.-J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.402 · Cited by 82
Liu, M., Chang, Y., Chen, S., Chuang, Y.-C., Chen, Y., Lin, C., & Chen, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208319 · Cited by 79
Bei, J., Jia, W.-H., & Zeng, Y.-X. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.012 · Cited by 73
Chiu, S.-H., Wu, C.-C., Fang, C., Yu, S., Hsu, H.-Y., Chow, Y., & Chen, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2323 · Cited by 72
Chen, Y.-R., Liu, M., Chang, Y., Wu, C.-C., Hu, C.-Y., & Chen, J. (2008) · Journal of Virology · doi:10.1128/jvi.00430-08 · Cited by 71
EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma
Li, Z., Duan, Y., Cheng, S., Chen, Y., Hu, Y., Zhang, L., He, J., Liao, Q., Yang, L., & Sun, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4552 · Cited by 70
Chan, K. C., Chan, L. S., Ip, J. C. Y., Lo, C., Yip, T. T. C., Ngan, R. K., Wong, R. N., Lo, K. W., Ng, W. T., Lee, A. W. M., et al. (2015) · Scientific Reports · doi:10.1038/srep09979 · Cited by 69
Self-citationFeederle, R., Neuhierl, B., Bannert, H., Geletneky, K., Shannon-Lowe, C. D., & Delecluse, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22727 · Cited by 65
Reactivation and lytic replication of EBV
Kenney, S. C. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.026 · Cited by 60
Su, W.-H., Hildesheim, A., & Chang, Y. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00299 · Cited by 59
PIK3CA mutations in nasopharyngeal carcinoma
Or, Y. Y., Hui, A. B., To, K., Lam, C. N.-Y., & Lo, K. W. (2005) · International Journal of Cancer · doi:10.1002/ijc.21444 · Cited by 57
Self-citationInhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma
Wang, G. L., Lo, K. W., Tsang, K. S., Chung, N. Y. F., Tsang, Y. S., Cheung, S., Lee, J. C. K., & Huang, D. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690818 · Cited by 53
Self-citationEpstein–Barr Virus Strain Variation
Farrell, P. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_4 · Cited by 53
Michaud, F., Coulombe, F., Gaudreault, É., Paquet‐Bouchard, C., Rola‐Pleszczynski, M., & Gosselin, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011908 · Cited by 52
Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients
Shen, Y. H., Zhang, S., Sun, R., Wu, T.-T., & Qian, J. (2015) · Emerging Microbes & Infections · doi:10.1038/emi.2015.20 · Cited by 52
Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma
Or, Y. Y. Y., Chung, G. T., To, K., Chow, C., Choy, K. W., Tong, C. Y., Leung, A. W.-C., Hui, A. B., Tsao, S., Ng, H., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2609 · Cited by 51
Self-citationChung, G. T., Lung, R. W. M., Hui, A. B., Yip, K. Y.-L., Woo, J. K. S., Chow, C., Tong, C. Y., Lee, S.-D., Yuen, J. W.-F., Lun, S. W., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4240 · Cited by 49
Self-citationEpstein–Barr virus‐induced epigenetic alterations following transient infection
Queen, K. J., Shi, M., Zhang, F., Cvek, U., & Scott, R. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27893 · Cited by 49
Iwakiri, D., Minamitani, T., & Samanta, M. (2013) · Journal of Virology · doi:10.1128/jvi.01089-13 · Cited by 41
Chou, C.-C., Chou, M.-J., & Tzen, C. (2008) · Medical Oncology · doi:10.1007/s12032-008-9124-5 · Cited by 37
Regulation of APC/CCdc20 activity by RASSF1A–APC/CCdc20 circuitry
Chow, C., Wong, N., Pagano, M., Lun, S. W.-M., Nakayama, K.-I., Nakayama, K., & Lo, K. W. (2011) · Oncogene · doi:10.1038/onc.2011.372 · Cited by 36
Self-citationSheu (2009) · International Journal of Oncology · doi:10.3892/ijo_00000486 · Cited by 33
Li, L., Zhang, Y., Guo, B. B., Chan, F. K. L., & Tao, Q. (2014) · 癌症:英文版 · doi:10.5732/cjc.014.10191 · Cited by 25
From Conventional to Next Generation Sequencing of Epstein-Barr Virus Genomes
Kwok, H. F., & Chiang, A. (2016) · Viruses · doi:10.3390/v8030060 · Cited by 24
Zhang, W., Han, D., Wan, P., Pan, P., Cao, Y., Liu, Y., Wu, K., & Wu, J. (2016) · Scientific Reports · doi:10.1038/srep34543 · Cited by 16
Cited by
The oral microbiome: diversity, biogeography and human health
Baker, J. L., Mark Welch, J. L., Kauffman, K. M., McLean, J. S., & He, X. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00963-6 · Cited by 661
The Global Landscape of EBV-Associated Tumors
Shannon-Lowe, C., & Rickinson, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00713 · Cited by 459
Cancer in Africa 2018: The role of infections
Parkin, D. M., Hämmerl, L., Ferlay, J., & Kantelhardt, E. J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32538 · Cited by 130
Functions of double‐negative B cells in autoimmune diseases, infections, and cancers
Chung, M. K. Y., Gong, L., Kwong, D. L., Lee, V. H., Lee, A. W., Guan, X., Kam, N., & Dai, W. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202217341 · Cited by 73
Lin, S., Zhou, H., Chen, G., Xue, J., Liu, Q., Li, J., Yang, Y., Zhao, Y., Bao, H., Huang, Y., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-12564-4 · Cited by 10
Metadata
- Authors
- Tsao, S. W., Tsang, C. M., & Lo, K. W.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2017-09-11
- Volume
- 372
- Issue
- 1732
- Pages
- 20160270
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2753803220
- Cited by
- 606
- References
- 118
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.